Discovery of a pyridine-piperazine-based small molecule that enhances the activity of peptidase neurolysin

Key Points

• Enhancing neurolysin activity suggests a novel approach to therapeutic intervention,
• The small molecule increases peptidase activity by 45%, offering promising implications for treatment efficacy.
• Chemical synthesis involved a pyridine-piperazine framework, yielding a viable candidate for neurolysin stimulation.
• Findings may enable future development of targeted therapies for neurodegenerative conditions.